Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2015
At a glance
- Drugs Eszopiclone (Primary) ; Zolpidem (Primary)
- Indications Depressive disorders; Generalised anxiety disorder; Insomnia
- Focus Pharmacokinetics
- 13 Jan 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 05 Aug 2009 Planned initiation date changed from 1 Jan 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov.
- 05 Aug 2009 Planned end date changed from 1 Mar 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.